Andrew A. F. Hack
2017
In 2017, Andrew A. F. Hack earned a total compensation of $2.1M as Former Chief Financial Officer at Editas Medicine.
Compensation breakdown
| Non-Equity Incentive Plan | $125,395 |
|---|---|
| Option Awards | $1,573,555 |
| Salary | $346,156 |
| Other | $6,350 |
| Total | $2,051,456 |
Hack received $1.6M in option awards, accounting for 77% of the total pay in 2017.
Hack also received $125.4K in non-equity incentive plan, $346.2K in salary and $6.4K in other compensation.
Rankings
In 2017, Andrew A. F. Hack's compensation ranked 5,382nd out of 14,666 executives tracked by ExecPay. In other words, Hack earned more than 63.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,382 out of 14,666 | 63rd |
Division Manufacturing | 1,932 out of 5,772 | 67th |
Major group Chemicals And Allied Products | 577 out of 2,075 | 72nd |
Industry group Drugs | 444 out of 1,731 | 74th |
Industry Biological Products, Except Diagnostic Substances | 80 out of 313 | 74th |
Source: SEC filing on April 26, 2019.
Hack's colleagues
We found three more compensation records of executives who worked with Andrew A. F. Hack at Editas Medicine in 2017.